Press release
Pharmaceutical Excipients Market Set to Reach USD 15.85 Billion by 2030
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฑ๐๐ข๐ฉ๐ข๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ข๐ฌ๐๐ ๐๐จ๐ซ ๐๐ข๐ ๐ง๐ข๐๐ข๐๐๐ง๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐กThe global pharmaceutical excipients market is experiencing substantial expansion, driven by advancements in drug delivery systems, the rising prevalence of chronic diseases, and the increasing adoption of biopharmaceuticals. In 2023, the market was valued at approximately USD 10 billion and is projected to reach USD 15.85 billion by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฑ๐๐ข๐ฉ๐ข๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Pharmaceutical excipients are inert substances formulated alongside active ingredients in medications to facilitate manufacturing processes, enhance stability, improve bioavailability, and ensure patient safety. They play a crucial role in the development of various dosage forms, including tablets, capsules, creams, and injections.
๐๐๐๐ฎ๐ซ๐ ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ๐๐๐ฒ: https://www.maximizemarketresearch.com/request-sample/6681/ ๏ปฟ
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ
๐ป๐๐๐๐๐๐๐๐๐๐๐๐ ๐จ๐ ๐๐๐๐๐๐๐๐๐๐: Innovations such as nanotechnology and controlled-release systems have increased the demand for specialized excipients that can achieve desired drug release profiles and improve patient compliance.
๐น๐๐๐๐๐ ๐ท๐๐๐๐๐๐๐๐๐ ๐๐ ๐ช๐๐๐๐๐๐ ๐ซ๐๐๐๐๐๐๐: The global increase in chronic health conditions has led to a higher demand for pharmaceutical products, thereby driving the need for effective excipients in drug formulations.
๐ฎ๐๐๐๐๐ ๐๐ ๐ฉ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐: The adoption of biopharmaceuticals, including monoclonal antibodies and gene therapies, is creating new opportunities for excipient manufacturers, particularly in stabilization and delivery applications.
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฑ๐๐ข๐ฉ๐ข๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ถ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐ฝ๐๐๐๐๐๐:
Vietnam's pharmaceutical sector is witnessing rapid growth, with increased investments in drug manufacturing and formulation. The government's supportive policies and the rising demand for generic medicines are creating significant opportunities for excipient manufacturers to establish a strong presence in the market.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ป๐๐๐๐ ๐ ๐๐ ๐ป๐๐๐๐๐๐๐ :
Thailand is experiencing a surge in pharmaceutical production, driven by advancements in drug formulation technologies. The country's focus on healthcare infrastructure development and increasing healthcare expenditure are contributing to the growing demand for high-quality excipients.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ฎ๐๐๐๐๐ ๐๐ ๐ฑ๐๐๐๐:
Japan's well-established pharmaceutical industry is characterized by continuous innovation and a strong emphasis on quality. The aging population and the consequent rise in chronic diseases are fueling the demand for advanced drug formulations, thereby driving the growth of the excipients market.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ถ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐บ๐๐๐๐ ๐ฒ๐๐๐๐:
South Korea's pharmaceutical sector is expanding, with significant investments in research and development. The country's focus on biotechnology and the development of novel drug delivery systems present opportunities for excipient manufacturers to collaborate on innovative solutions.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ป๐๐๐๐ ๐ ๐๐ ๐บ๐๐๐๐๐๐๐๐:
Singapore's strategic position as a pharmaceutical hub in Asia, coupled with its robust regulatory framework, makes it an attractive market for excipient manufacturers. The nation's emphasis on quality assurance and advanced manufacturing practices aligns with the growing demand for specialized excipients.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ช๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐ ๐ผ๐๐๐๐๐ ๐บ๐๐๐๐๐:
The U.S. pharmaceutical excipients market is characterized by consolidation, with major players engaging in mergers and acquisitions to enhance their product portfolios. For instance, in June 2023, ๐๐๐ต๐น๐ฎ๐ป๐ฑ introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant, simplifying development processes and improving tablet quality.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ผ๐๐ ๐๐๐๐๐ ๐๐ ๐ช๐๐๐๐:
Despite geopolitical tensions, major global pharmaceutical companies are pursuing deals in China to enhance their drug pipelines and establish a stronger presence in the market. In 2024, ๐๐ฌ๐ญ๐ซ๐๐๐๐ง๐๐๐ acquired China-based cell therapy developer ๐๐ซ๐๐๐๐ฅ๐ฅ ๐๐ข๐จ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ for $1.2 billion, reflecting the ongoing interest in the Chinese pharmaceutical sector.
๐ท๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ฌ๐๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ป๐๐๐๐ ๐ ๐๐ ๐ฌ๐๐๐๐๐:
Europe remains a significant market for pharmaceutical excipients, with a strong focus on innovation and quality standards. The region's stringent regulatory environment and the presence of leading pharmaceutical companies drive the demand for high-quality excipients.
๐๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐๐๐ค ๐ข๐ง๐ฌ๐ข๐๐? ๐๐ซ๐๐ ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ: https://www.maximizemarketresearch.com/request-sample/6681/
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฑ๐๐ข๐ฉ๐ข๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ, ๐๐๐ ๐ฆ๐๐ง๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
๐๐ฎ ๐๐ง๐ค๐๐ช๐๐ฉ
Organic Chemicals
Inorganic Chemicals
Others
๐๐ฎ ๐๐ช๐ฃ๐๐ฉ๐๐ค๐ฃ๐๐ก๐๐ฉ๐ฎ
Fillers & Diluents
Suspending & Viscosity Agents
Coating Agents
Binders
Flavoring Agents & Sweeteners
Disintegrants
Others
The market is divided into Oral Formulations, Tablets, Capsules, Liquid Formulations, and Others based on formulation. The pharmaceutical excipients market share is anticipated to be highest during the forecast period, with the oral formulation segment dominating the market in 2023. The oral formulation segment, which includes excipients used in the creation of oral dosage forms such tablets, capsules, powders, and solutions meant for oral administration, makes up a sizeable portion of the pharmaceutical excipients industry. Because of their cost-effectiveness, patient acceptability, ease of administration, and convenience, oral formulations are among the most popular and commonly used dosage forms.
๐๐ฎ ๐๐ค๐ง๐ข๐ช๐ก๐๐ฉ๐๐ค๐ฃ
Oral Formulations
Tablets
Capsules
Liquid Formulations
Others
Fillers & Diluents, Suspending and Viscosity Agents, Coating Agents, Binders, Flavouring Agents and Sweeteners, Disintegrants, and Others are the market segments based on formulation. The pharmaceutical excipients market share is anticipated to be highest during the forecast period, with the binders segment dominating the market in 2023. When it comes to the formulation of solid dosage forms like tablets and granules, binder is an essential component. In order to give pharmaceutical formulations cohesive qualities and enable the granulation of powders into compact, cohesive units, binder-also referred to as adhesives or granulating agents-is added. The integrity, consistency, and mechanical strength of the finished dosage form are guaranteed by this excipient category, which is anticipated to accelerate the expansion of the pharmaceutical excipients market.
๐๐ฎ ๐๐ฃ๐-๐๐จ๐๐ง
Pharmaceutical Companies
Biotechnology Companies
Others
๐๐จ ๐๐๐ฅ๐ฏ๐ ๐๐๐๐ฉ๐๐ซ ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก, ๐ค๐ข๐ง๐๐ฅ๐ฒ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ฅ๐ข๐ง๐ค: https://www.maximizemarketresearch.com/request-sample/6681/
๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐ฑ๐๐ข๐ฉ๐ข๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ, ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
North America:
1. Colorcon (United States)
2. Ashland Global Holdings Inc. (United States)
3. Avantor, Inc. (United States)
4. Lubrizol Corporation (United States)
5. Roquette America, Inc. (United States)
6. Dow Chemical Company (United States)
Europe:
7. Croda International Plc (United Kingdom)
8. BASF SE (Germany)
9. Evonik Industries AG (Germany)
10. Meggle Pharma (Germany)
11. JRS Pharma GmbH & Co. KG (Germany)
12. DFE Pharma (Netherlands)
13. Merck KGaA (Germany)
14. Kerry Group plc (Ireland)
Asia-Pacific:
15. Shin-Etsu Chemical Co., Ltd. (Japan)
16. Nipro Corporation (Japan)
17. Colorcon Asia-Pacific (Singapore)
18. Signet Chemical Corporation Pvt. Ltd. (India)
19. Associated British Foods (Australia)
Latin America:
20. Blanver (Brazil)
21. Cristรกlia (Brazil)
๐๐ข๐๐ฐ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ซ ๐๐จ๐ฉ๐ข๐๐ฌ ๐๐จ๐ฐ:
Latin America Medical Imaging Market https://www.maximizemarketresearch.com/market-report/latin-america-medical-imaging-market/3386/
Pension Administration Software Market https://www.maximizemarketresearch.com/market-report/pension-administration-software-market/186952/
Global Oral Thin Films Market https://www.maximizemarketresearch.com/market-report/global-oral-thin-films-market/36409/
Global Custom Procedure Trays and Packs Market https://www.maximizemarketresearch.com/market-report/global-custom-procedure-trays-and-packs-market/55194/
Shea Butter Market https://www.maximizemarketresearch.com/market-report/global-shea-butter-market/23770/
Visual Effects (VFX) Market https://www.maximizemarketresearch.com/market-report/visual-effects-vfx-market-global-market/148265/
India Cloud Infrastructure as a Service (IaaS) Market https://www.maximizemarketresearch.com/market-report/india-cloud-infrastructure-as-a-service-iaas-market/44086/
Automotive Wiper Market https://www.maximizemarketresearch.com/market-report/automotive-wiper-market/42504/
India NonLife Insurance Market https://www.maximizemarketresearch.com/market-report/india-non-life-insurance-market/42091/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Excipients Market Set to Reach USD 15.85 Billion by 2030 here
News-ID: 3833344 • Views: โฆ
More Releases from Maximize Market Research Pvt. Ltd.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โฆ

Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โฆ

Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโฆ

Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโฆ
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringโฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโฆ